Educational Activities Archives

Developed by AAAP and ASAM, this guideline focuses on the identification, diagnosis, treatment, and promotion of recovery for patients with stimulant use disorder, stimulant intoxication, and stimulant withdrawal.

As we enhance our understanding of addiction medicine through research, we strive to improve the treatment outcomes for our patients. Substance Use Disorder (SUD) at its core is an effective combination treatment because although medication is extremely beneficial in the treatment of addictions, for many patients it is not sufficient to maintain recovery because it does not address the behavioral aspects of the disease of addiction. This module provides basic information on 4 Evidence-Based Practices (EBPs) that effectively treat the behavioral aspects of the disease of addiction. This module includes examples of techniques that may be performed during medication management and/or longer counseling visits with patients.

The current opioid and drug overdose crisis continues to have a devastating impact on morbidity and mortality in the United States. With the rise in use of potent synthetic opioids like fentanyl in the drug supply, creating linkages to comprehensive substance use related services is critical. Opioid Treatment Programs (OTP) and the comprehensive care and services they provide play a vital role in addressing this need, yet challenges remain. Despite clear evidence of the benefits of OTP’s, access to OTPs in some parts of the country is limited; stigma related to the use of methadone remains a challenge. Yet in the face of these headwinds, many OTPs are providing comprehensive leading-edge services to address the opioid and drug overdose crisis.

The use of technology is prevalent in almost every aspect of our life in America. Many depend on technology to work and connect. It is only fitting for clinicians working in the field of addiction to wonder about the long-term consequence of repeated prolonged exposure to technologies and social media that are perfectly tailored to keep us engaged at all times. In this episode, Dr. Petros Levounis, professor and chair of the Department of Psychiatry and associate dean for professional development at Rutgers New Jersey Medical School, and current APA president-elect will discuss technological addiction and provide his approach to diagnosis and management, as well as advice for trainees and early-career psychiatrists.

View the toolkit.

As a member of the committee that developed the CDC opioid guidelines and a primary care physician who treats chronic pain patients, Dr. Roger Chou is a uniquely situated authority in the conversation on opioid management. In episode one Dr. Chou talked about the guidelines themselves and, in this episode, he rejoins the podcast to discuss his personal experiences in applying the CDC guidelines in challenging patient cases and gives his impressions on sample cases physicians often encounter. Dr. Chou serves as an Associate Professor of Medicine/General Internal Medicine and Geriatrics and Medical Informatics and Clinical Epidemiology at Oregon Health & Science University. He is also Scientific Director of the Oregon Evidence-based Practice Center, funded by the Agency for Healthcare Research and Quality (AHRQ), and an Investigator for the Scientific Resource.